TUCSON, Ariz., Oct. 23, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today that two of its leading Digital Pathology scientists will present the latest advancements in digital pathology multiplexing and algorithm assisted breast cancer testing at the Pathology Visions Conference in Baltimore, MD USA from October 28 – 31, 2012.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/ventana-scientists-to-reveal-latest-advancements-in-multiplexing-gene-and-protein-targets-for-personalized-medicine-and-breast-cancer-testing-at-pathology-visions-2012-175301321.html
Dr. Pascal Bamford, project lead for Ventana Multiplex and Molecular Assays, will present the key concepts of multiplexing gene and protein targets in tissue and discuss the importance and current challenges of translating this technology to the clinical setting. Multiplexing genomic and proteomic targets in Formalin-fixed, Paraffin-embedded (FFPE) tissue is widely regarded as a key enabling technology in the future of personalized medicine and companion diagnostics.
Dr. Gerardo Fernandez , Medical Director for Digital Pathology at Ventana will discuss the evolution of automated algorithmic analysis of the standard breast cancer immunohistochemistry (IHC) panel, from the pitfalls of early scoring techniques to the more robust late generation methods in use today ."Ventana is committed to Digital Pathology and leads the industry with robust image analysis solutions for clinical applications," says Steve Burnell, PhD, Lifecycle Leader for Digital Pathology and Workflow at Ventana. In addition to sharing the latest advancements in digital pathology, Ventana will also present the latest versions of its Virtuoso digital pathology image and workflow management software and VANTAGE workflow solution for histology lab specimen tracking at Pathology Visions 2012. With Virtuoso 5.3, a web-based software, Ventana has expanded the user interface to 21 languages, making it easy for international customers to adopt this new technology. The software orchestrates the digital slide workflow from the moment the slide is scanned until the slide image is viewed and the case results reported.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV